Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Growth Outlook Through 2024-2033

Overview and Scope
Polymerase Chain Reactions (PCR) devices and reagents are designed to aid scientists in producing multiple copies of specific DNA segments. In PCR, a section of the genome to be amplified is chosen using short synthetic DNA fragments called primers, and the segment is subsequently amplified through numerous rounds of DNA synthesis.

Sizing and Forecast
The polymerase chain reactions (pcr) devices, reagents and uses market size has grown strongly in recent years. It will grow from $5.9 billion in 2023 to $6.19 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to rising prevalence of infectious diseases, increasing demand for clinical diagnostic services, growing demand for personalized medicine, increasing adoption of pcr in research and development.

The polymerase chain reactions (pcr) devices, reagents and uses market size is expected to see strongly grown in the next few years. It will grow to $8.25 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to covid-19 and infectious disease monitoring, cancer diagnostics and liquid biopsies, agricultural and environmental applications, expansion of pharmacogenomics, genomic research advancements. Major trends in the forecast period include digital pcr, multiplex pcr, next-generation sequencing (ngs) integration, miniaturization and portable devices, ai and data analytics, automation and robotics.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/polymerase-chain-reactions-devices-reagents-and-uses-global-market-report

Segmentation & Regional Insights
The polymerase chain reactions (pcr) devices, reagents and uses market covered in this report is segmented –

1) By Product: Instruments, Reagents, Consumables
2) By Instruments: Standars PCR, RT-PCR, Digital PCR
3) By End User: Pharmaceutical and biotechnoly industries, Clinical Diagnostics labs and hospitals, Academics and research organization

North America was the largest region in the polymerase chain reactions (PCR) devices and reagents market in 2023. Western Europe was the second-largest region in the global polymerase chain reactions (PCR) devices and reagents market report. The regions covered in the polymerase chain reactions (PCR) devices, reagents and uses market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2485&type=smp

Major Driver Impacting Market Growth
The growing prevalence of infectious diseases across the world is driving the polymerase chain reactions devices and reagents market. Polymerase chain reactions devices are used in clinical laboratories to detect the presence of infectious diseases. In a report published by the World Health Organization, it was reported that around 17 million people are killed in a year due to infectious diseases. Also, the same report stated that 30 new infectious diseases have emerged in the last 20 years. According to the National Centre for Health Statistics, 15.5 million people in the US visited a physician, due to an infectious disease. Such instances are increasing the demand for clinical diagnostic services and thereby driving the polymerase chain reactions devices and reagents market.

Key Industry Players
Major companies operating in the polymerase chain reactions (PCR) devices, reagents and uses market include Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Abbott Laboratories, bioMérieux S.A., Agilent Technologies Inc., QIAGEN N.V., Siemens Healthcare GmbH (Siemens AG), Fluidigm Corporation, SYGNIS Pharma AG, Takara Bio Inc., Cepheid, Lontech Laboratories, Eppendorf India Private Limited, GE Healthcare, Kapa Biosystems, Maxim Biomedical Inc., Promega Corporation, RainDance Technologies Inc., Affymetrix Inc., Beckman Coulter Inc., Enzo Life Sciences Inc., Roche Diagnostics GmbH, Merck KGaA, Danaher Corporation, Stilla Technologies, Meridian Bioscience Inc., BioFire Diagnostics LLC, Luminex Corporation, GenMark Diagnostics Inc.

The polymerase chain reactions (pcr) devices, reagents and uses market report table of contents includes:

1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model